Glenn Haifer 博士和 Ampersand Capital Partners 收購澳大利亞生物製品 CDMO Luina Bio，更名為 AcuraBio
Aug 31, 2022 12:00 HKT |  |
|
글렌 하이퍼 박사와 앰퍼샌드 캐피탈 파트너스, 호주의 바이오로직스 CDMO 루이나 바이오 인수 후 아쿠라바이오로 리브랜딩
Aug 31, 2022 12:00 HKT | |
|
아방스 클리니컬, 인포마파마인텔리전스 어워드 2022에서 올해의 바이오테크 기업상 후원
Aug 31, 2022 11:00 HKT |  |
|
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
Aug 30, 2022 21:00 HKT | |
|
海普瑞2022上半年净利润大增46.5% 集团业绩实现逆市攀升
Aug 30, 2022 14:38 HKT |  |
|
海普瑞2022上半年淨利潤大增46.5% 集團業績實現逆市攀升
Aug 30, 2022 14:37 HKT | |
|
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue
Aug 30, 2022 14:00 HKT |  |
|
Avance 临床赞助商在 2022 年 Informa Pharma Intelligence Awards 中获得年度生物技术公司奖
Aug 30, 2022 06:00 HKT | |
|
Avance 臨床贊助商在 2022 年 Informa Pharma Intelligence Awards 中獲得年度生物技術公司獎
Aug 30, 2022 06:00 HKT | |
|
贝康医疗公布2022年中期业绩 做强技术创新
Aug 29, 2022 18:32 HKT |  |
|
貝康醫療公佈2022年中期業績 做強技術創新
Aug 29, 2022 18:31 HKT | |
|
Strengthen technological innovation, Basecare Medical Announces 2022 Interim Results
Aug 29, 2022 18:30 HKT | |
|
Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022
Aug 29, 2022 18:00 HKT | |
|
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region
Aug 29, 2022 14:00 HKT | |
|
Sirnaomics核心产品STP705在治疗皮肤基底细胞癌II期临床试验组别中实现100%完全清除
Aug 29, 2022 12:48 HKT | |
|
Sirnaomics核心產品STP705在治療皮膚基底細胞癌II期臨床試驗組別中實現100%完全清除
Aug 29, 2022 12:47 HKT | |
|
Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma
Aug 29, 2022 12:46 HKT | |
|
Sirnaomics推进基于GalAhead(TM)递送平台的RNAi疗法，用于治疗补体介导相关疾病
Aug 26, 2022 20:17 HKT | |
|
Sirnaomics推進基於GalAhead(TM)遞送平台的RNAi療法，用於治療補體介導相關疾病
Aug 26, 2022 20:16 HKT | |
|
Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases
Aug 26, 2022 20:15 HKT | |
|